Merck & Co. Inc. (MRK)

Merck (MRK) is attractively valued, boasting strong free cash flow, robust margins, and a leading position in oncology with Keytruda. MRK faces a looming patent cliff for Keytruda in 2028, but a stron...

Merck shares climb nearly 14% as Pfizer's landmark drug pricing deal with the Trump administration sparked renewed optimism in pharma stocks.

The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.

Verizon (VZ -1.25%) is currently the highest-yielding stock in the Dow Jones Industrial Average (DJINDICES: ^DJI), and it isn't even close. The wireless carrier is shelling out 6.3% of its market cap ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision...

The October 2025 high-yield dividend watchlist highlights 10 stocks with an average forward yield of 3.95% and a projected 19.02% return. This month's selection process lowered the yield threshold to ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30.

An agreement with the U.S. government and a favorable regulatory decision in Europe helped lift shares of large drugmakers. Meanwhile, the announcement of a collaboration that will integrate shopping ...